Skip to main content
Equibles

MORGAN STANLEY

Position in IBIO — iBio, Inc.

CIK 895421 NEW YORK, NY
Back to IBIO Full portfolio

Position in IBIO

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$16
-$58,762 QoQ
Shares Held
10
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#50
of 55 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 30% Shared 0% None 70%

Common Shares in IBIO Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

MORGAN STANLEY holds $16,838,649,954 across 523 Biotechnology names. IBIO ranks #505 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RPRX
Royalty Pharma plc
 42,931,597 $2,407,174,637
2 VRTX
Vertex Pharmaceuticals Inc / Ma
 3,242,139 $1,610,467,694
3 ROIV
Roivant Sciences Ltd.
 42,592,905 $1,507,362,901
4 REGN
Regeneron Pharmaceuticals, Inc.
 1,397,712 $871,529,332
5 MRNA
Moderna, Inc.
 9,538,094 $667,952,718
6 ARGX
Argenx SE
 643,123 $596,670,219
7 TECH
BIO-TECHNE Corp
 6,374,717 $450,373,747
8 INCY
Incyte Corp
 2,948,364 $334,226,536

All Filings in IBIO

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $16 10
2026-03-31 $58,778 30,937
2025-12-31 $53,256 27,595
2025-09-30 $45 57
2025-06-30 $35 49
2025-03-31 $15,174 3,775
2024-12-31 $117 48
2024-09-30 $105 48
2024-06-30 $102 49
2024-03-31 $1,087 268
2023-12-31 $463 339
2023-09-30 $2,175 7,254
2023-06-30 $4,361 7,151
2023-03-31 $4,227 2,033
2022-12-31 $3,136 7,131
2022-09-30 $10,466 61,575
2022-06-30 $86,669 333,354
2022-03-31 $65,252 151,754
2021-12-31 $87,732 159,518
2021-09-30 $138,127 130,311
2021-06-30 $245,137 162,344
2021-03-31 $160,779 104,403
2020-12-31 $322,843 307,471
2020-09-30 $630,582 310,632
2020-06-30 $66,854 30,115
2020-03-31 $3,922 3,700